<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294653/" ref="ordinalpos=4652&amp;ncbi_uid=7087775&amp;link_uid=PMC4294653" image-link="/pmc/articles/PMC4294653/figure/f9-dddt-9-349/" class="imagepopup">Figure 9.  From: Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells. </a></div><br /><div class="p4l_captionBody">Proteomic analysis revealed networks of signaling pathways regulated by PLB in DU145 cells.<b>Notes:</b> Networks of signaling pathways were analyzed by IPA according to 267 molecules and 107 related pathways which were regulated by PLB in DU145 cells.<b>Abbreviations:</b> cAMP, cyclic adenosine monophosphate; IPA, Ingenuity Pathway Analysis; PLB, plumbagin.</div></div>